Answers are grounded in this paper and cite their sources.
The constant need for cancer diagnosis in the early stages drives the development of contrast agents and imaging methods.
No takes yet. Share an insight, caveat, or question.
Abaei et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: